ATE305008T1 - Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen - Google Patents

Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen

Info

Publication number
ATE305008T1
ATE305008T1 AT00973591T AT00973591T ATE305008T1 AT E305008 T1 ATE305008 T1 AT E305008T1 AT 00973591 T AT00973591 T AT 00973591T AT 00973591 T AT00973591 T AT 00973591T AT E305008 T1 ATE305008 T1 AT E305008T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
releasing hormone
hormone receptor
gonadotropin releasing
related uses
Prior art date
Application number
AT00973591T
Other languages
English (en)
Inventor
Yun-Fei Zhu
Timothy D Gross
Yinghong Gao
Patrick J Connors Jr
Zhiqiang Guo
Chen Chen
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of ATE305008T1 publication Critical patent/ATE305008T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00973591T 1999-10-15 2000-10-16 Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen ATE305008T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41876899A 1999-10-15 1999-10-15
PCT/US2000/028677 WO2001029044A1 (en) 1999-10-15 2000-10-16 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Publications (1)

Publication Number Publication Date
ATE305008T1 true ATE305008T1 (de) 2005-10-15

Family

ID=23659500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973591T ATE305008T1 (de) 1999-10-15 2000-10-16 Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen

Country Status (11)

Country Link
EP (1) EP1220857B1 (de)
JP (1) JP2003512379A (de)
KR (1) KR20020045609A (de)
AT (1) ATE305008T1 (de)
AU (1) AU769855B2 (de)
CA (1) CA2386942A1 (de)
DE (1) DE60022769T2 (de)
ES (1) ES2249302T3 (de)
HK (1) HK1047437B (de)
MX (1) MXPA02003614A (de)
WO (1) WO2001029044A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1255738E (pt) 2000-01-25 2012-06-19 Neurocrine Biosciences Inc Antagonistas do receptor da hormona de libertação da gonadotrofina e métodos relacionados com os mesmos
WO2002102401A1 (en) 2001-04-30 2002-12-27 Zentaris Gmbh Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists
US6740656B2 (en) 2001-08-02 2004-05-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
WO2003011293A2 (en) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
WO2003011841A1 (en) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists
MXPA04000985A (es) * 2001-08-02 2005-02-17 Neurocrine Biosciences Inc Piridin-4-onas sustituidas y su uso como antagonistas del receptor de hormona de liberacion de gonadotropina.
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
WO2003068769A1 (en) 2002-02-12 2003-08-21 Pfizer Inc. Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
WO2003106446A1 (en) 2002-06-13 2003-12-24 Pfizer Inc. Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
WO2005007633A1 (en) 2003-07-07 2005-01-27 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
KR20060052790A (ko) 2003-07-07 2006-05-19 뉴로크린 바이오사이언시즈 인코퍼레이티드 고나도트로핀-방출 호르몬 수용체 길항제로서의피리미딘-2,4-디온 유도체
SI1646389T1 (sl) 2003-07-07 2009-02-28 Neurocrine Biosciences Inc Derivati pirimidin-2,4-diona kot antagonisti receptorja gonadotropin sproĺ äśajoäśega hormona
CL2008000986A1 (es) 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
CN101678007B (zh) 2007-04-06 2013-07-03 纽罗克里生物科学有限公司 促性腺激素释放激素受体拮抗剂及其制药用途
EP2231671B1 (de) 2007-12-13 2013-04-24 Vertex Pharmaceuticals Incorporated Modulatoren des zystische-fibrose-transmembran-leitfähigkeit-regulators
CN101987865B (zh) * 2009-07-29 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 含有乙内酰脲结构的促黄体生成素释放激素拮抗剂
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2012175514A1 (en) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Pyridinone derivatives and pharmaceutical compositions thereof
BR112014021331B1 (pt) * 2012-02-28 2020-12-15 Tiumbio Co., Ltd Antagonistas do receptor do hormônio liberador de gonadotropina, composição farmacêutica compreendendo os mesmos e uso desses
JPWO2014133112A1 (ja) * 2013-03-01 2017-02-02 国立大学法人 東京大学 オートタキシン阻害活性を有する8−置換イミダゾピリミジノン誘導体
KR101973074B1 (ko) * 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
CR20220308A (es) 2019-11-25 2022-08-04 Amgen Inc Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1277612A (zh) * 1997-12-26 2000-12-20 武田药品工业株式会社 含氮杂环化合物及其制备方法和用途
US6081508A (en) * 1998-02-25 2000-06-27 Indus River Networks, Inc. Remote computer communication
EP1067930A4 (de) * 1998-04-02 2002-09-18 Merck & Co Inc Antagonisten des gonadoliberins

Also Published As

Publication number Publication date
KR20020045609A (ko) 2002-06-19
MXPA02003614A (es) 2002-10-23
DE60022769D1 (de) 2006-02-02
DE60022769T2 (de) 2006-07-06
EP1220857B1 (de) 2005-09-21
AU769855B2 (en) 2004-02-05
ES2249302T3 (es) 2006-04-01
AU1208901A (en) 2001-04-30
CA2386942A1 (en) 2001-04-26
JP2003512379A (ja) 2003-04-02
WO2001029044A1 (en) 2001-04-26
HK1047437A1 (en) 2003-02-21
HK1047437B (zh) 2005-12-16
EP1220857A1 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
ATE305008T1 (de) Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen
ATE548357T1 (de) Gonadotropin freisetzende hormon rezeptor antagonisten und ihre verwandten verfahren
IL172833A0 (en) Pyrimidine-2,4-dione derivatives and pharmaceutical compositions containing the same
IL172834A0 (en) Pyrimidine-,2,4-dione derivatives and pharmaceutical compositions containing the same
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
HUP0203870A2 (hu) Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény
WO2003011293A3 (en) Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
MX2009010828A (es) Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos.
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
EP1106605A4 (de) Antagonisten des andrenergen-alpha1b-rezeptors
BR0317600A (pt) ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
IL142893A0 (en) Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
DE60208803D1 (de) 1,3,5-triazine-2,4,6-trione, herstellung und anwendungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
EA200200831A1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
ATE557007T1 (de) Arylpyrimidine geeignet zur behandlung von sexualhormonbedingten zuständen wie endometriose, prostatakrebs und dergleichen
DE60318716D1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
HK1072935A1 (en) Condensed camptothecins as antitumor agents
UA83870C2 (ru) Замещенные бицикло[3.1.1]гептаном производные бензимидазолона и хиназолинона как агонисты человеческих рецепторов orl1
DE60314158D1 (de) Pyrazolderivate als gnrh-inhibitoren
TH52968A3 (th) การใช้แบบใหม่

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties